Research Article

Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines

Volume: 5 Number: 2 August 31, 2022
EN TR

Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines

Abstract

Objective: Recent studies have shown that sulfated polysaccharides obtained from marine algae have many biological and physiological activities. Kappa-carrageenan, a sulfated polysaccharide obtained from red marine algae, is known to have anti-proliferative effects in various cancer cell lines. In this study, the cytotoxic effect of kappa-carrageenan on two different cell lines, namely the malignant MCF-7 breast cancer cell line and the non-malignant SVCT breast epithelial cell lines, was investigated in an in vitro model.

Materials & Methods: Three different concentrations of carrageenan were prepared for each cell in its own medium, with an initial dose of 1000 µg/ml (Dilution I: 1000 µg/ml; Dilution II: 250 µg/ml; Dilution III: 62.5 µg/ml). Cells were incubated with carrageenan at the doses set for each experimental group. Cells incubated in a carrageenan-free medium comprised the control group.

Results: To measure cell viability, 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) analysis was performed. Cell morphology was investigated by the acridine orange (AO)/propidium iodide (PI) fluorescent staining method. The present results indicated that carrageenan caused cytotoxic effects on both malignant and non-malignant cell lines.

Conclusion: Considering that the different phenotypic features of the subtypes of the MCF-7 cell line may affect cell viability and cell proliferation, cell selection should be performed very carefully in cytotoxicity studies. We suggest that using the MCF-7 cell line for cytotoxicity experiments needs to contemplate this important phenomenon for further experimental setups.

Keywords

References

  1. 1. Yuana H, Songa J, Lia X, Lia N, Daia J. Immunomodulation and antitumor activity of k-carrageenan oligosaccharides. Cancer Lett. 2006; 243: 228-234.
  2. 2. Necas J, Bartosikova L. Carrageenan: a review. Vet Med. 2013; 58 (4): 187-205.
  3. 3. Yuana H, Songa J, Lia X, Lia N, Daia J. Enhanced immunostimulatory and antitumor activity of different derivatives of κ-carrageenan oligosaccharides from Kappaphycus striatum. J Appl Phycol. 2011; 23:59–65.
  4. 4. Hu X, Jiang X, Aubree E, Boulenguer P, Critchley AT. Preparation and In Vivo. Antitumor Activity of κ-Carrageenan Oligosaccharides. Pharm Biol. 2006; 44(9): 646-650.
  5. 5. Pangestuti R, Kim SK. Biological Activities of Carrageenan. Adv Food Nutr. 2014; 72: 113-114.
  6. 6. Khotimchenkoa M, Tiastoa V, Kalitnkb MB et al. Antitumor potential of carrageenans from marine red algae. Carbohydr Polym. 2020; 116568.
  7. 7. Guo Z, Wei Y, Zhang Y et al. Carrageenan oligosaccharides: A comprehensive review of preparation, isolation, purification, structure, biological activities and applications. Algal Res. 2022; 61: 102593.
  8. 8. Kubat E, Gürpınar ÖA, Ertuğrul G et al. Is enoxaparin sodium exactly safe for subcutaneous fibroblast?: A cell culture study. Acta Med Alanya. 2021; 5 (1): 18-23.

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences, Clinical Sciences

Journal Section

Research Article

Publication Date

August 31, 2022

Submission Date

April 28, 2022

Acceptance Date

July 5, 2022

Published in Issue

Year 2022 Volume: 5 Number: 2

APA
Sayın, M., Sevim Akan, H., Atalay, Ö., Kubat, E., & Gurpinar, Ö. A. (2022). Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines. Ege Tıp Bilimleri Dergisi, 5(2), 35-39. https://doi.org/10.33713/egetbd.1110113
AMA
1.Sayın M, Sevim Akan H, Atalay Ö, Kubat E, Gurpinar ÖA. Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines. Ege Tıp Bilimleri Dergisi. 2022;5(2):35-39. doi:10.33713/egetbd.1110113
Chicago
Sayın, Merve, Handan Sevim Akan, Özbeyen Atalay, Emre Kubat, and Özer Aylin Gurpinar. 2022. “Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the Non-Malignant SVCT Breast Epithelial Cell Lines”. Ege Tıp Bilimleri Dergisi 5 (2): 35-39. https://doi.org/10.33713/egetbd.1110113.
EndNote
Sayın M, Sevim Akan H, Atalay Ö, Kubat E, Gurpinar ÖA (August 1, 2022) Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines. Ege Tıp Bilimleri Dergisi 5 2 35–39.
IEEE
[1]M. Sayın, H. Sevim Akan, Ö. Atalay, E. Kubat, and Ö. A. Gurpinar, “Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines”, Ege Tıp Bilimleri Dergisi, vol. 5, no. 2, pp. 35–39, Aug. 2022, doi: 10.33713/egetbd.1110113.
ISNAD
Sayın, Merve - Sevim Akan, Handan - Atalay, Özbeyen - Kubat, Emre - Gurpinar, Özer Aylin. “Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the Non-Malignant SVCT Breast Epithelial Cell Lines”. Ege Tıp Bilimleri Dergisi 5/2 (August 1, 2022): 35-39. https://doi.org/10.33713/egetbd.1110113.
JAMA
1.Sayın M, Sevim Akan H, Atalay Ö, Kubat E, Gurpinar ÖA. Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines. Ege Tıp Bilimleri Dergisi. 2022;5:35–39.
MLA
Sayın, Merve, et al. “Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the Non-Malignant SVCT Breast Epithelial Cell Lines”. Ege Tıp Bilimleri Dergisi, vol. 5, no. 2, Aug. 2022, pp. 35-39, doi:10.33713/egetbd.1110113.
Vancouver
1.Merve Sayın, Handan Sevim Akan, Özbeyen Atalay, Emre Kubat, Özer Aylin Gurpinar. Cytotoxic Activity of Carrageenan on Malignant MCF-7 Breast Cancer and the non-Malignant SVCT Breast Epithelial Cell Lines. Ege Tıp Bilimleri Dergisi. 2022 Aug. 1;5(2):35-9. doi:10.33713/egetbd.1110113

Cited By

The articles published in this journal are licensed under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).